Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Triple antithrombotic therapy
DRUG
2 trials
Sponsors
Central Hospital, Nancy, France
, The First Affiliated Hospital with Nanjing Medical University
Conditions
Acute Coronary Syndrome (ACS)
Bleeding
Non-valvular Atrial Fibrillation (NVAF)
Phase 4
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
NCT03234114
The First Affiliated Hospital with Nanjing Medical University
Acute Coronary Syndrome (ACS), Non-valvular Atrial Fibrillation (NVAF)
Start: 2018-02-03
End: 2024-12-31
Target: 3746
Updated: 2023-04-24
Unknown Phase
Bleeding Events After Triple Antithrombotic Therapy Initiation.
NCT03203980
Central Hospital, Nancy, France
Bleeding
Start: 2017-07-15
End: 2018-07-15
Target: 200
Updated: 2017-07-11